UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of ovarian research, ISSN 1757-2215, 05/2014, Volume 7, Issue 1, pp. 57 - 57
Targeted therapies | Angiogenesis | Primary peritoneal cancer | Fallopian tube cancer | Bevacizumab | Ovarian cancer | Life Sciences & Biomedicine | Reproductive Biology | Science & Technology | Humans | Angiogenesis Inhibitors - pharmacology | Neovascularization, Pathologic - diet therapy | Molecular Targeted Therapy | Randomized Controlled Trials as Topic | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antibodies, Monoclonal, Humanized - pharmacology | Female | Ovarian Neoplasms - blood supply | Ovarian Neoplasms - drug therapy | Oncology, Experimental | Research | Cancer | Studies | Chemotherapy | Womens health | Vascular endothelial growth factor | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1915 - 1928
Humans | Middle Aged | Antibodies, Monoclonal, Humanized/therapeutic use | Antimetabolites, Antineoplastic/therapeutic use | Male | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | Fluorouracil/therapeutic use | Progression-Free Survival | Cetuximab/therapeutic use | Antineoplastic Agents, Immunological/therapeutic use | Squamous Cell Carcinoma of Head and Neck/drug therapy | Female | Aged | Head and Neck Neoplasms/drug therapy | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Head and Neck Neoplasms - drug therapy | Squamous Cell Carcinoma of Head and Neck - mortality | Cetuximab - therapeutic use | Fluorouracil - therapeutic use | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Agents, Immunological - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Squamous Cell Carcinoma of Head and Neck - drug therapy | Head and Neck Neoplasms - mortality | Squamous cell carcinoma | Chemotherapy | Metastasis | Analysis | Cancer | Medical research | 5-Fluorouracil | Mortality | Oncology | Survival | Metastases | Population (statistical) | Pembrolizumab | Hypotheses | Randomization | Platinum | Cell death | PD-L1 protein | Population | Head and neck cancer | Ligands | Larynx | Safety | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Cutaneous and ocular toxicology, ISSN 1556-9527, 01/2020, Volume 39, Issue 1, pp. 10 - 12
Journal Article
International journal of clinical oncology, ISSN 1341-9625, 4/2019, Volume 24, Issue 4, pp. 411 - 419
Medicine & Public Health | Renal cancer | FGF | Second-line, temsirolimus | Oncology | Cancer Research | Metastatic | Surgical Oncology | Bevacizumab | Life Sciences & Biomedicine | Science & Technology | Antimitotic agents | Carcinoma | Plants | Metastasis | Antineoplastic agents | Growth factors | Cancer | Index Medicus
Journal Article
Anticancer research, ISSN 0250-7005, 02/2020, Volume 40, Issue 2, pp. 929 - 938
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Deoxycytidine - pharmacology | Male | Treatment Outcome | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Aged, 80 and over | Female | Aged | Deoxycytidine - analogs & derivatives | Bile Duct Neoplasms - drug therapy | Biliary tract | Chemotherapy | Metastasis | Gemcitabine | Response rates | Metastases | Index Medicus
Journal Article
Anticancer research, ISSN 0250-7005, 01/2020, Volume 40, Issue 1, pp. 435 - 441
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Greece | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Imatinib Mesylate - therapeutic use | DNA Mutational Analysis | Gastrointestinal Stromal Tumors - drug therapy | Imatinib Mesylate - adverse effects | Female | Imatinib | Mutation | Safety | Survival | Tumors | Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 05/2013, Volume 13, Issue 1, pp. 263 - 263
Metronomic-chemotherapy | Antiangiogenic | Vinorelbine | Cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Young Adult | Antineoplastic Agents, Phytogenic - administration & dosage | Vinblastine - analogs & derivatives | Biomarkers, Tumor - metabolism | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Real-Time Polymerase Chain Reaction | Prostatic Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - pathology | Prostatic Neoplasms - pathology | Enzyme-Linked Immunosorbent Assay | Time-to-Treatment | Administration, Oral | RNA, Messenger - genetics | Translational Medical Research | Liver Neoplasms - drug therapy | Survival Rate | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Prostatic Neoplasms - mortality | Breast Neoplasms - pathology | Adolescent | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Metastasis | Index Medicus
Journal Article
International journal of colorectal disease, ISSN 0179-1958, 11/2019, Volume 34, Issue 11, pp. 1871 - 1877
Irinotecan | Single-nucleotide polymorphisms | Chemotherapy | Medicine & Public Health | miRNAs | mCRC | Surgery | Hepatology | Gastroenterology | Internal Medicine | Proctology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Irinotecan - therapeutic use | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Adult | Colorectal Neoplasms - secondary | Female | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Index Medicus
Journal Article
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, ISSN 1436-3291, 10/2011, Volume 14, Issue 4, pp. 317 - 321
Caspase 9 | Gene polymorphisms | Caspase 8 | Medicine & Public Health | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Surgical Oncology | Gastric cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Caspase 8 - genetics | Stomach Neoplasms - genetics | Genetic Predisposition to Disease | Caspase 9 - genetics | Gene Frequency | Humans | Middle Aged | Female | Aged | Stomach Neoplasms - mortality | Case-Control Studies | Polymorphism, Genetic | Anopheles | Genes | Medical colleges | Genetic research | Genetic aspects | Disease susceptibility | Health aspects | Stomach cancer | Cancer | Index Medicus
Journal Article
Anticancer research, ISSN 0250-7005, 01/2020, Volume 40, Issue 1, pp. 305 - 313
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasm Recurrence, Local - pathology | Neoplasms - complications | Thrombosis - etiology | Hemorrhage - etiology | Humans | Middle Aged | Risk Factors | Female | Male | Thrombosis - therapy | Anticoagulants | Coagulation | Risk analysis | Thrombosis | Trauma | Bleeding | Risk factors | Molecular weight | Bevacizumab | Body mass index | Renal insufficiency | Body mass | Low molecular weights | Body size | Heparin | Thromboembolism | Cancer | Index Medicus
Journal Article
Journal of translational medicine, ISSN 1479-5876, 01/2012, Volume 10, Issue 1, pp. 10 - 10
Mrna expression | Anthracyclines | Gene amplification | Top2a | Randomized study | Cish | Early breast cancer | Taxanes | Her2 | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Multivariate Analysis | Receptors, Estrogen - metabolism | Antibiotics, Antineoplastic - pharmacology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Ki-67 Antigen - metabolism | Gene Expression Profiling | RNA, Messenger - metabolism | Receptors, Progesterone - metabolism | DNA-Binding Proteins - metabolism | Dose-Response Relationship, Drug | Paraffin Embedding | Young Adult | Poly-ADP-Ribose Binding Proteins | Breast Neoplasms - enzymology | Antigens, Neoplasm - metabolism | Adult | Female | Chemotherapy, Adjuvant | Gene Expression Regulation, Neoplastic - drug effects | Tissue Fixation | Genes, Neoplasm - genetics | Antigens, Neoplasm - genetics | DNA Topoisomerases, Type II - metabolism | RNA, Messenger - genetics | Risk Factors | Proportional Hazards Models | Treatment Outcome | DNA-Binding Proteins - genetics | Breast Neoplasms - drug therapy | Breast Neoplasms - genetics | Antibiotics, Antineoplastic - therapeutic use | Breast Neoplasms - pathology | Epirubicin - therapeutic use | DNA Topoisomerases, Type II - genetics | Aged | Epirubicin - pharmacology | Genes | Physiological aspects | Breast cancer | Genetic aspects | Research | Epirubicin | Drug therapy | Health aspects | DNA topoisomerase II | Medical research | Oncology | Cytotoxicity | Cancer therapies | Manuscripts | Medicine | Pathology | Chemotherapy | Hospitals | Writing | Drug dosages | Tumors | Index Medicus | TOP2A | early breast cancer | CISH | taxanes | anthracyclines | HER2 | gene amplification | randomized study | mRNA expression
Journal Article